Dr. Edith Mitchell, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
ASCO press conference: Giving colon cancer patients a combination of moisturisers, sunscreen, topical steroids and antibiotics before they receive the targeted therapy panitumumab (Vectibix) reduced the incidence of a common, severe skin rash by more than half.